Elan shares plummet after drug withdrawal

Shares in Elan have plummeted today as the company withdrew a drug used to treat multiple sclerosis.

Elan shares plummet after drug withdrawal

Shares in Elan have plummeted today as the company withdrew a drug used to treat multiple sclerosis.

The company withdrew the drug Tysabri after it was linked to a death of a person who took a combination therapy which includes the drug.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited